New data from an observational analysis of high-risk populations reveals a concerning correlation: prophylactic doxycycline use is associated with higher prevalence of resistance-associated mutations in Mycoplasma genitalium. The September 2026 study, published in the International Journal of Infectious Diseases, analyzed populations with documented M. genitalium exposure and elevated STI burden.
Selective pressure from doxycycline emerged as a high-risk factor for resistance emergence, alongside inadequate dosing or compliance issues and frequent sexual network transmission. These findings highlight the complex dynamics between antimicrobial prophylaxis and pathogen adaptation in sexually active populations. The data underscore the importance of monitoring resistance patterns in real-world prevention programs. Read the full article on GMJ Newsroom.
Was this article helpful?
